Luísa Bouwman is a Regulatory Affairs Professional with more than 10 years of experience in the pharmaceutical industry and a PhD Candidate in Regulatory Science at the University of Lisbon (Portugal). Her research focuses on evidence generation for orphan medicines in the European Union, providing practical insights into regulatory decision-making, innovative clinical development strategies, and the evolving role of real-world evidence in rare diseases.